Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is currently recommended as a standard therapeutic strategy to restore reperfusion and improve functional outcomes in patients with AIS. The gene discussed is PLAT; the disease is androgen insensitivity syndrome.